Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.14-0.10 (-1.38%)
At close: 4:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.24
Open7.19
Bid7.12 x 4000
Ask7.23 x 4000
Day's Range6.89 - 7.40
52 Week Range2.56 - 23.42
Volume6,356,490
Avg. Volume4,726,646
Market Cap2.11B
Beta (5Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)-2.53
Earnings DateNov 03, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.83
  • PR Newswire

    Amyris To Present At The Evercore ISI 4th Annual HealthCONx Conference On December 1, 2021

    Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1st at 3:30 pm ET.

  • TipRanks

    3 “Strong Buy” Stocks Under $10 That Are Poised for a Breakout Year

    2021 has been a fantabulous year for stock investors, with the S&P 500 returning 25% year to date. But here’s the bad news: all good things must come to an end, and the clock’s ticking down to the end of 2021. But here’s the good news, too: 2022 might also be not too shabby a year for stocks. Most of Wall Street’s pros believe we’ll see between 8% and 12% growth going forward. That’s a sound return, and in line with the market’s long-term overall gains. What investors need to do now is optimize

  • PR Newswire

    Amyris To Host Call Regarding Recent Financing Activity

    Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that it will host a conference call and live webcast to discuss its recent financing activity on Monday, November 22, 2021 beginning at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss the Company's recent

Advertisement
Advertisement